Event Cardio Group Inc.

CIK:0001394130|SEC Filings

Statements of Operations (Unaudited)	3 Months Ended				9 Months Ended
Statements of Operations (Unaudited)	May 31, 2016 $ / shares	May 31, 2016 CAD shares	May 31, 2015 $ / shares	May 31, 2015 CAD shares	May 31, 2016 $ / shares	May 31, 2016 CAD shares	May 31, 2015 $ / shares	May 31, 2015 CAD shares
Income Statement [Abstract]
Revenue
Operating Expenses
General and administrative		276,465		378,001		1,032,018		681,473
Research and development - related party		356,156		185,549		640,332		323,778
Research and development - other		11,969		56,111		116,079		132,981
Total Operating Expenses		644,590		619,661		1,788,429		1,138,232
Loss from Operations		(644,590)		(619,661)		(1,788,429)		(1,138,232)
Other Expenses
Interest expense - related parties		29,069		15,749		68,019		55,818
Interest expense - other				3,500		13,080		3,500
Amortization - loan costs		13,187		9,443		103,859		26,857
Loss before Income Tax Credit		(686,846)		(648,353)		(1,973,387)		(1,224,407)
Net Loss		(686,846)		(648,353)		(1,973,387)		(1,224,407)
Other Comprehensive Income
Foreign currency translation adjustment		(138,619)		(13,694)		233,168		62,827
Comprehensive Loss		CAD (825,465)		CAD (662,047)		CAD (1,740,219)		CAD (1,161,580)
Loss per Share:
Basic and Diluted loss per share \| $ / shares	$ (0.005)		$ (0.007)		$ (0.016)		$ (0.013)
Weighted Average Number of Shares Outstanding Basic and Diluted \| shares		134,259,353		98,720,647		122,500,433		92,065,904

Statements of Cash Flows (Unaudited) - CAD	9 Months Ended
Statements of Cash Flows (Unaudited) - CAD	May 31, 2016	May 31, 2015
Cash Flows from Operating Activities
Net loss	CAD (1,973,387)	CAD (1,224,407)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of prepaid expenses	729,379	212,579
Warrants issued for research and development - related party	78,996
Depreciation of property and equipment	904	1,016
Amortization of financing costs	103,859	22,741
Stock based compensation	34,746	113,125
Income from investment in Medpac Asia Pacific Unit Trust	(6,332)
Changes in assets and liabilities:
Prepaid expenses	(31,083)	(141,099)
Accounts payable	(78,074)	217,925
Net cash used in operating activities	(1,140,992)	(798,120)
Cash Flows from Investing Activities
Deposit on equipment purchase	(100,000)
Purchase of property and equipment		(150,000)
Net cash used in investing activities	(100,000)	(150,000)
Cash Flows from Financing Activities
Repayments of due to related parties	(14,577)	(27,566)
Advances from related parties		14,434
Proceeds from notes payable - related parties	76,886	195,822
Proceeds from convertible notes payable		500,000
Proceeds from issuance of common shares	982,581	197,000
Proceeds received on equity instruments to be issued	16,451
Net cash provided by financing activities	1,061,341	879,690
Effect of exchange rate on cash	218,472	16,430
Increase (Decrease) in Cash	38,821	(52,000)
Cash, beginning of period	32,427	86,617
Cash, end of period	71,248	34,617
Non-Cash Supplemental Cash Flow Information:
Issuance of common shares and common share purchase warrants for services recorded as prepaid expenses	367,552
Issuance of common shares for investment in Medpac Asia Pacific Unit Trust	200,000
Issuance of convertible not payable - related party for notes payable - related parties, accrued interest and financing costs	671,351
Issuance of common share purchase warrants for financing costs	CAD 59,247

Balance Sheets (Unaudited) - CAD	May 31, 2016	Aug. 31, 2015
Current Assets
Cash	CAD 71,248	CAD 32,427
Prepaid expenses	387,382	568,537
Financing costs, net		105,999
Total Current Assets	458,630	706,963
Investment in Medpac Asia Pacific Unit Trust	206,332
Prepaid expenses - non-current portion	245,278	392,516
Property and Equipment, net	305	1,214
Deposit on equipment purchase	250,000	150,000
Financing Costs, net	88,071
TOTAL ASSETS	1,248,616	1,250,693
Current Liabilities
Accounts payable	425,658	598,835
Due to related parties	41,708	55,864
Notes payable - related parties		549,502
Total Current Liabilities	467,366	1,204,201
Convertible Notes Payable - Related Parties	1,258,053	525,000
TOTAL LIABILITIES	1,725,419	1,729,201
Stockholders' Deficit
Preferred stock, $0.001 par value; 10,000,000 shares authorized; nil shares issued and outstanding at May 31, 2016 and 10,000,000 issued and outstanding at August 31, 2015		10,000
Common stock, 300,000,000 shares authorized at $0.001 par value, 135,895,856 shares issued and outstanding at May 31, 2016 and 109,460,321 issued and outstanding at August 31, 2015	135,894	109,460
Additional paid in capital	4,272,653	2,110,237
Equity instruments to be issued	56,451	168,950
Subscriptions receivable	(324,427)
Accumulated other comprehensive income	336,600	103,432
Accumulated deficit	(4,953,974)	(2,980,587)
TOTAL STOCKHOLDERS' DEFICIT	(476,803)	(478,508)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	CAD 1,248,616	CAD 1,250,693